Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel vs Vinorelbine in Elderly Advanced NSCLC
NCT00148291Phase 3Completed
- Sponsor
- West Japan Oncology Group
- Start
- Jun 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by West Japan Oncology Group. Started Jun 1999; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00148291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148291.